Research Topics
| Lisa BeroSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The power of paperwork: how Philip Morris neutralized the medical code for secondhand smokeDaniel M Cook
Center for Tobacco Control Research and Education, University of California, San Francisco (UCSF, USA
Health Aff (Millwood) 24:994-1004. 2005..Philip Morris's reaction reveals the importance of policy decisions related to data collection and paperwork...- Science in regulatory policy making: case studies in the development of workplace smoking restrictionsL A Bero
Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA 94142 0936, USA
Tob Control 10:329-36. 2001..To study the role of science related and other arguments in the development of workplace smoking regulations... - Framing processes in public commentary on US federal tobacco control regulationAndrew L Roth
Institute for Health Policy Studies, University of California, San Francisco, 94143, USA
Soc Stud Sci 33:7-44. 2003..An orientation to the dynamics of framing and counter-framing contributes to an understanding of the relationship between scientific evidence and public commentary in the formulation of controversial health policy regulations... - The limits of competing interest disclosuresL A Bero
Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, USA
Tob Control 14:118-26. 2005.... - Managing financial conflicts of interest in researchLisa A Bero
Department of Clinical Pharmacy and Health Policy, University of California, San Francisco, USA
J Am Coll Dent 72:4-9. 2005..Differences of opinion exist in the research community over whether disclosure of financial interests, although necessary, is sufficient to ensure a reasonable level of freedom from bias and to maintain public trust... - Implications of the tobacco industry documents for public health and policyLisa Bero
Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, California 94143 0613, USA
Annu Rev Public Health 24:267-88. 2003..The paper concludes with a discussion of the implications of tobacco document research for public health and the application of such research to fields other than tobacco control... - Tobacco industry manipulation of researchLisa A Bero
Department of Clinical Pharmacy, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
Public Health Rep 120:200-8. 2005 - Tobacco industry research and protection of human subjects: a case study of R. J. ReynoldsJenny White
Department of Clinical Pharmacy, University of California, San Francisco, CA, USA
Nicotine Tob Res 9:1213-25. 2007..Policymakers should consider expanding the scope of federal human subjects research regulations to cover research undertaken by private firms such as tobacco companies... - Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategyK G Shojania
Department of Medicine, University of California, San Francisco, San Francisco, Calif, USA
Eff Clin Pract 4:157-62. 2001..Unfortunately, the few published strategies for identifying these articles involve MEDLINE interfaces not widely available outside of academic medicine. In addition, the performance of these strategies is unknown... - Cigars, youth, and the Internet linkR E Malone
Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94143, USA
Am J Public Health 90:790-2. 2000..This study examined the accessibility and appeal to youth of cigar marketing sites on the Internet... - Scientific quality of original research articles on environmental tobacco smokeD E Barnes
Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94109, USA
Tob Control 6:19-26. 1997.... - Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analysesBETH HART
Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, 3333 California St, Suite 420, San Francisco, CA 94118, USA
BMJ 344:d7202. 2012..To investigate the effect of including unpublished trial outcome data obtained from the Food and Drug Administration (FDA) on the results of meta-analyses of drug trials... - "Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterpriseLisa Bero
University of California, Clinical Pharmacy and Health Policy, 3333 California Street, Suite 420, San Francisco, CA, USA
J Clin Epidemiol 61:629-33. 2008 - Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentationKristin Rising
School of Medicine, University of California San Francisco, San Francisco, California, USA
PLoS Med 5:e217; discussion e217. 2008.... - Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersLisa Bero
Clinical Pharmacy and Health Policy, University of California, San Francisco, California, United States of America
PLoS Med 4:e184. 2007.... - Policy makers' perspectives on tobacco control advocates' roles in regulation developmentT Montini
Department of Social and Behavioral Sciences, and Institute for Health Policy Studies, University of California, San Francisco, California 94143-0936, USA
Tob Control 10:218-24. 2001..CONCLUSIONS: There is an important role for tobacco control advocates in the policy development process in regulatory agencies... - An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciencesTracey J Woodruff
University of California, San Francisco, CA, USA
Health Aff (Millwood) 30:931-7. 2011..The methodology can also support professional societies, health care organizations, government agencies, and others in developing prevention-oriented guidelines for use in clinical and policy settings... - Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomesNancy Nkansah
University of California San Francisco, 155 North Fresno Street Suite 224, Fresno, CA 93701, USA
Public Health Nutr 12:1931-7. 2009..To explore the relationship between industry sponsorship of Ca supplementation studies in healthy children and study outcomes... - To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008Lisa Bero
Department of Clinical Pharmacy, University of California, 3333 California Street Suite 420, San Francisco, CA 94118, United States of America
Bull World Health Organ 88:922-9. 2010..to assess drug donations in terms of their adherence to the drug donation guidelines put forth by the World Health Organization (WHO)... - Financial ties and conflicts of interest between pharmaceutical and tobacco companiesBhavna Shamasunder
Institute for Health Policy Studies, University of California, San Francisco, USA
JAMA 288:738-44. 2002..Thus, because tobacco cessation product marketing has been altered as a result of these financial conflicts, disclosure would serve the interest of public health... - Characteristics of materials distributed by drug companies. An evaluation of appropriatenessD Stryer
Kayenta Health Center, Indian Health Service, San Francisco, CA, USA
J Gen Intern Med 11:575-83. 1996..The material contains both educational and promotional characteristics... - Cigar magazines: using tobacco to sell a lifestyleL D Wenger
Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California 94143-0936, USA
Tob Control 10:279-84. 2001..Public health advocates should anticipate and challenge other new tobacco marketing vehicles as communications technologies advance and public spaces for smoking shrink... - Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewJoel Lexchin
School of Health Policy and Management, York University, Toronto, ON, Canada M3J 1P3
BMJ 326:1167-70. 2003.... - How the tobacco industry responded to an influential study of the health effects of secondhand smokeMi-Kyung Hong
Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, Box 0613, San Francisco, CA 94143-0613, USA
BMJ 325:1413-6. 2002 - Narrative review: the promotion of gabapentin: an analysis of internal industry documentsMichael A Steinman
San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California 94143, USA
Ann Intern Med 145:284-93. 2006..Such documents have become available through litigation concerning the promotion of gabapentin (Neurontin, Pfizer, Inc., New York, New York) for off-label uses... - Assessing the evidence submitted in the development of a workplace smoking regulation: the case of MarylandTheresa Montini
Department of Social and Behavioral Sciences and Institute for Health Policy Studies, University of California at San Francisco, San Francisco, CA 94143, USA
Public Health Rep 117:291-8. 2002.... - Identifying carcinogens: the tobacco industry and regulatory politics in the United StatesDaniel M Cook
Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
Int J Health Serv 36:747-66. 2006..However, the tobacco industry's participation in the regulatory process influenced the process in favor of all regulated industry... - Impact of a collaborative pharmacy practice model on the treatment of depression in primary carePatrick R Finley
Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco (UCSF, San Francisco, USA
Am J Health Syst Pharm 59:1518-26. 2002.... - The creation of industry front groups: the tobacco industry and "get government off our back"Dorie E Apollonio
Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
Am J Public Health 97:419-27. 2007..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior... - Characteristics and impact of drug detailing for gabapentinMichael A Steinman
Affairs Medical Center, San Francisco, California, United States of America
PLoS Med 4:e134. 2007..In this study, we evaluated the content and impact of detail visits for gabapentin by analyzing market research forms completed by physicians after receiving a detail visit for this drug... - Evaluating public commentary and scientific evidence submitted in the development of a risk assessmentMarieka S Schotland
Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco 94143-0936, USA
Risk Anal 22:131-40. 2002..Critics and supporters of the risk assessment used different criteria to evaluate the scientific evidence, suggesting that they were socially constructing the evidence to support their positions... - Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?Judith J Prochaska
Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
Schizophr Bull 34:555-67. 2008.... - Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisionsElizabeth A Boyd
Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143 0613, USA
Sci Eng Ethics 13:415-35. 2007.... - Tobacco industry sponsorship of a book and conflict of interestMi-Kyung Hong
Department of Clinical Pharmacy and Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA
Addiction 101:1202-11. 2006..Scientists who collaborate on publications sponsored by the tobacco industry must consider the full implications of these joint efforts... - Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journalsKirby P Lee
University of California, San Francisco, CA, USA
Med J Aust 184:621-6. 2006..To identify characteristics of submitted manuscripts that are associated with acceptance for publication by major biomedical journals... - Financial conflict-of-interest policies in clinical research: issues for clinical investigatorsElizabeth A Boyd
Department of Clinical Pharmacy, University of California, San Francisco, 94143, USA
Acad Med 78:769-74. 2003.... - Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trialPatrick R Finley
Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California 94143 0622, USA
Pharmacotherapy 23:1175-85. 2003..Clinical pharmacists had a favorable effect on multiple aspects of patient care. Future studies of this model in other health care settings appear warranted... - Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industryJenny White
Department of Clinical Pharmacy, Center for Tobacco Control Research and Education, University of California, San Francisco 94143, USA
Am J Public Health 94:240-50. 2004..This evidence suggest that tobacco control advocates should expect a vigorous response from the tobacco industry to policy advocacy efforts, particularly at the local level... - Implementation of financial disclosure policies to manage conflicts of interestElizabeth A Boyd
University of California, San Francisco, Department of Clinical Pharmacy, USA
Health Aff (Millwood) 23:206-14. 2004..Our study suggests the importance of local culture and context for institutional decision making... - Conflicts of interest in academic research: policies, processes, and attitudesShira Lipton
University of California, Los Angeles, Los Angeles, CA, USA
Account Res 11:83-102. 2004.... - High school journalists' perspectives on tobaccoRuth E Malone
Department of Social and Behavioral Sciences, School of Nursing, University of California, San Francisco 94143, USA
J Health Commun 7:139-56. 2002..Youth journalists should also be included in media advocacy efforts... - Comparison of review articles published in peer-reviewed and throwaway journalsPaula A Rochon
Kunin Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Department of Medicine, University of Toronto, Toronto, Ontario, Canada M6A 2E1
JAMA 287:2853-6. 2002..To compare the quality, presentation, readability, and clinical relevance of review articles published in peer-reviewed and "throwaway" journals... - Legislating "sound science": the role of the tobacco industryAnnamaria Baba
Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
Am J Public Health 95:S20-7. 2005..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions... - Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality ruleKatherine Bryan-Jones
Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California San Francisco, 94143-1390, USA
Am J Public Health 93:585-92. 2003..CONCLUSIONS: Our findings suggest that regulatory authorities must take into account the source, motivation, and validity of arguments used in the regulatory process in order to make accurately informed decisions... - Association of journal quality indicators with methodological quality of clinical research articlesKirby P Lee
Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, CA, USA
JAMA 287:2805-8. 2002..CONCLUSIONS: High citation rates, impact factors, and circulation rates, and low manuscript acceptance rates and indexing on Brandon/Hill Library List appear to be predictive of higher methodological quality scores for journal articles... - Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictionsPeggy Lopipero
Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California 94143 0613, USA
Tob Control 15:323-32. 2006..To understand the evolution of 20 years of tobacco industry strategies to undermine federal restrictions of smoking on aircraft in the United States... - Reporting science and conflicts of interest in the lay pressDaniel M Cook
School of Public Health, University of Nevada, Reno, Nevada, United States of America
PLoS ONE 2:e1266. 2007..Forthright reporting of financial ties and conflicts of interest of researchers is associated with public trust in and esteem for the scientific enterprise... - Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort studyVeronica Yank
Stanford University, Stanford Medical Group, Stanford, CA 94305 5765, USA
BMJ 335:1202-5. 2007..To determine whether financial ties to one drug company are associated with favourable results or conclusions in meta-analyses on antihypertensive drugs... - Prevalence of honorary and ghost authorship in Cochrane reviewsGraham Mowatt
Health Services Research Unit, University of Aberdeen, Polwarth Bldg, Foresterhill, Aberdeen AB25 2ZD, Scotland
JAMA 287:2769-71. 2002..To determine the prevalence of honorary and ghost authorship in Cochrane reviews, how authorship is assigned, and the ways in which authors and Cochrane editorial teams contribute... - Evidence based medicine: increasing, not dictating, choiceKay Dickersin
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA
BMJ 334:s10. 2007 - The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case studyNancy Thai Nguyen
Clionical Pharmacy and Health Policy, University of California-San Francisco, 3333 Ca;lifornia Street, San Francisco, CA 94143, USA
Clin Ther 28:1231-43. 2006..There is a need to establish structured procedures to achieve an optimal level of uniformity and transparency in advisory committee processes... - Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancerJohnny Beney
Institut central des hôpitaux valaisans, Sion Switzerland
Pharmacotherapy 22:1301-11. 2002..To evaluate the effect of telephone follow-up on the physical well-being dimension of health-related quality of life in patients with cancer... - Attitudes of academic and clinical researchers toward financial ties in research: a systematic reviewBonnie E Glaser
University of California, San Francisco, CA 94143-0613, USA
Sci Eng Ethics 11:553-73. 2005..However, their trust in disclosure as a way to manage conflicts may reveal a lack of awareness of the actual impact of financial incentives on themselves and other researchers... - "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state governmentChristopher J Jewell
University of California, San Francisco 94143 0613, USA
Milbank Q 86:177-208. 2008..The real-life context in which policymakers are situated and make decisions also is crucial to the development of evidence-informed policy...
Research Grants
- A Qualitative Study of Editorial Decision-MakingLisa Bero; Fiscal Year: 2003..abstract_text> ..
- Management Decisions in Financial Conflicts of InterestLisa Bero; Fiscal Year: 2002..Our findings will allow us to develop a framework for decision-making regarding conflict identification and management. ..